WebBefore you get started, make sure you qualify for IpsiHand screening and therapy. Based on FDA indications and Neurolutions requirements, candidates are required to meet the following criteria: Adult age 18 or older. 6 months or more post-stroke. Experience post-stroke upper extremity weakness. Resident of the United States WebMay 3, 2024 · The IpsiHand System has been cleared for use in chronic stroke patients to facilitate muscle re-education through its novel BCI platform. In addition to the De Novo Authorization, the IpsiHand device notably received Breakthrough Device designation from the FDA as well.
DE NOVO CLASSIFICATION R NEUROLUTIONS …
WebThe Neurolutions IpsiHand Upper Extremity Rehabilitation System (a.k.a. Neurolutions System or IpsiHand System) detects goal-oriented brain activity using non-invasive EEG … WebApr 8, 2024 · Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. ClinicalTrials.gov Identifier: NCT04338971 easter boards for school
Treatment of Chronic Stroke With IpsiHand - Full Text View ...
WebApr 29, 2024 · Neurolutions, a company with offices in Santa Cruz, CA and St. Louis, MO, won FDA de novo authorization to introduce its IpsiHand stroke rehab system in the … WebApr 28, 2024 · The IpsiHand system includes a wearable robotic exoskeleton that fits over a patient's hand and wrist and assists with opening and closing the hand based on the … WebApr 23, 2024 · IpsiHand uses non-invasive electroencephalography (EEG) electrodes — instead of an implanted electrode or other invasive feature — to record brain activity. EEG data is then wirelessly transmitted to a tablet for analysis of the intended motor function and the signal is sent to a wireless electronic hand brace designed to move the patient’s hand. easter bone china